Is there a window of opportunity to optimize trastuzumab cardiac monitoring?

BACKGROUND: It remains unclear whether the current arbitrary screening recommendations of trastuzumab-related cardiotoxicity provides an adequate balance between preventing heart damage and curtailing a curative treatment. AIM: To determine the incidence rate and consequences of trastuzumab-induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Rala de Paula, Bruno Henrique, Costa, Maria Eduarda Teixeira Ferro, de Sousa, Carlos Augusto Moreira, Bines, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350605/
https://www.ncbi.nlm.nih.gov/pubmed/36161060
http://dx.doi.org/10.4330/wjc.v14.i7.403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350605/
https://www.ncbi.nlm.nih.gov/pubmed/36161060
http://dx.doi.org/10.4330/wjc.v14.i7.403

Ejemplares similares